Complete response rate after chemotherapy was 83.8% (95% CI, 71.1 - 96.5%), progression-free survival (PFS) rate at 12-month was 82.5%, 2-year PFS was 78.7%; overall survival (OS) rate at 12 - month was 82.3%, 2-year OS was 82.3%.